1
|
Johnson EL, Chang YT, Davit B, Gidal BE, Krauss GL. Assessing bioequivalence of generic modified-release antiepileptic drugs. Neurology 2016; 86:1597-604. [PMID: 27016518 DOI: 10.1212/wnl.0000000000002607] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/30/2015] [Accepted: 12/28/2015] [Indexed: 11/15/2022] Open
Abstract
OBJECTIVES The purpose of this study was to determine how closely generic modified-release antiepileptic drugs (MR-AEDs) resemble reference (brand) formulations by comparing peak concentrations (Cmax), total absorption (area under the curve [AUC]), time to Cmax (Tmax), intersubject variability, and food effects between generic and reference products. METHODS We tabulated Cmax and AUC data from the bioequivalence (BE) studies used to support the approvals of generic Food and Drug Administration-approved MR-AEDs. We compared differences in 90% confidence intervals of the generic/reference AUC and Cmax geometric mean ratios, and intersubject variability, Tmax and delivery profiles and food effects. RESULTS Forty-two MR-AED formulations were studied in 3,175 healthy participants without epilepsy in 97 BE studies. BE ratios for AUC and Cmax were similar between most generic and reference products: AUC ratios varied by >15% in 11.4% of BE studies; Cmax varied by >15% in 25.8% of studies. Tmax was more variable, with >30% difference in 13 studies (usually delayed in the fed compared to fasting BE studies). Generic and reference MR products had similar intersubject variability. Immediate-release AEDs showed less intersubject variability in AUC than did MR-AEDs. CONCLUSIONS Most generic and reference MR-AEDs have similar AUC and Cmax values. Ratios for some products, however, are near acceptance limits and Tmax values may vary. Food effects are common with MR-AED products. High variability in pharmacokinetic values for once-a-day MR-AEDs suggests their major advantage compared to immediate-release AED formulations may be the convenience of less frequent dosing to improve adherence.
Collapse
Affiliation(s)
- Emily L Johnson
- From the Department of Neurology (E.L.J., G.L.K.), The Johns Hopkins University School of Medicine, Baltimore, MD; Johnson & Johnson (Y.-T.C.), New Brunswick; Merck & Co., Inc. (B.D.), Kenilworth, NJ; and University of Wisconsin (B.E.G.), School of Pharmacy, Madison, WI.
| | - Yi-Ting Chang
- From the Department of Neurology (E.L.J., G.L.K.), The Johns Hopkins University School of Medicine, Baltimore, MD; Johnson & Johnson (Y.-T.C.), New Brunswick; Merck & Co., Inc. (B.D.), Kenilworth, NJ; and University of Wisconsin (B.E.G.), School of Pharmacy, Madison, WI
| | - Barbara Davit
- From the Department of Neurology (E.L.J., G.L.K.), The Johns Hopkins University School of Medicine, Baltimore, MD; Johnson & Johnson (Y.-T.C.), New Brunswick; Merck & Co., Inc. (B.D.), Kenilworth, NJ; and University of Wisconsin (B.E.G.), School of Pharmacy, Madison, WI
| | - Barry E Gidal
- From the Department of Neurology (E.L.J., G.L.K.), The Johns Hopkins University School of Medicine, Baltimore, MD; Johnson & Johnson (Y.-T.C.), New Brunswick; Merck & Co., Inc. (B.D.), Kenilworth, NJ; and University of Wisconsin (B.E.G.), School of Pharmacy, Madison, WI
| | - Gregory L Krauss
- From the Department of Neurology (E.L.J., G.L.K.), The Johns Hopkins University School of Medicine, Baltimore, MD; Johnson & Johnson (Y.-T.C.), New Brunswick; Merck & Co., Inc. (B.D.), Kenilworth, NJ; and University of Wisconsin (B.E.G.), School of Pharmacy, Madison, WI
| |
Collapse
|
2
|
Graudins LV, Dooley MJ. Generic medicines literacy — minimising the potential for patient confusion. Med J Aust 2010; 193:427. [DOI: 10.5694/j.1326-5377.2010.tb03980.x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/21/2010] [Accepted: 07/25/2010] [Indexed: 11/17/2022]
|
3
|
Once-daily dosing is appropriate for extended-release divalproex over a wide dose range, but not for enteric-coated, delayed-release divalproex: evidence via computer simulations and implications for epilepsy therapy. Epilepsy Res 2009; 87:260-7. [PMID: 19892524 DOI: 10.1016/j.eplepsyres.2009.09.015] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/23/2009] [Revised: 09/02/2009] [Accepted: 09/20/2009] [Indexed: 11/22/2022]
Abstract
Divalproex sodium extended-release (divalproex-ER), administered once-daily, maintains plasma valproic acid (VPA) concentrations for 24h, whereas enteric-coated, delayed-release divalproex sodium (divalproex) requires multiple-daily doses to do the same. We hypothesize that a once-daily divalproex regimen should not be administered to epilepsy patients requiring high total daily doses, e.g., 35.6-56 mg/kg/day, due to the potential for high (>125 mg/L) maximum VPA concentrations (C(max)). We examined the impact of once-daily dosing, divalproex vs. divalproex-ER, on steady-state plasma VPA concentration-time profiles at commonly used doses in monotherapy (uninduced) and polytherapy (hepatic enzyme-induced) virtual adult patients. Only the 1125 mg once-daily divalproex dose had mean C(max)<100mg/L; >or=2000 mg produced mean C(max)>or=125 mg/L. Mean divalproex C(min) was approximately 50 mg/L at two of four doses tested, whereas mean ER C(min) was >73 mg/L at all doses tested. Once-daily divalproex peak-trough fluctuation was 4.4-6.2-fold greater than once-daily divalproex-ER. We predict that excursions beyond the conventional recommended VPA plasma concentration range will commonly occur with high total mg daily doses (>or=2000 mg) of enteric-coated divalproex, if dosed once-daily, potentially producing clinical toxicity. This divalproex formulation should not be dosed once-daily at high total mg daily doses due to this risk. Divalproex-ER is the appropriate formulation for administration on a once-daily basis, especially if large total mg/day doses are required for the control of seizure activity.
Collapse
|